Medison Pharma; Alnylam Pharmaceuticals

Alnylam Pharmaceuticals and Medison Pharma Announce the Expansion of Their Collaboration to a Multi-Regional Partnership to Commercialize RNAi Therapeutics - Zug, Switzerland (ots/PRNewswire) – Alnylam Pharmaceuticals, Inc. ( (Nasdaq: ALNY), the leading RNAi therapeutics company, and Medison Pharma ( (“Medison”), a global pharma company focused on providing access to highly innovative therapies for patients in international markets, have announced an expansion of their existing partnership to a multi-regional agreement that includes Poland, Czech Republic, Hungary, […]